Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies (Q71843089)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

title

Factor V Leiden increases the risk of thrombosis in patients with antiphospholipid antibodies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

author name string

S K Lo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

J E Salmon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

L R Sammaritano

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

R L Silverstein

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

publication date

1 December 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

page(s)

361-365

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

Antiphospholipid antibody syndrome: immunologic and clinical aspects

21 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

Activation of cultured vascular endothelial cells by antiphospholipid antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

Activated protein C resistance caused by Arg506Gln mutation in factor Va

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

Resistance to activated protein C as a basis for venous thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

The 1982 revised criteria for the classification of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

Anticardiolipin antibodies: isotype distribution and phospholipid specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

Brief report: variability of thrombosis among homozygous siblings with resistance to activated protein C due to an Arg-->Gln mutation in the gene for factor V

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

A racial difference in the prevalence of the Arg506-->Gln mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

Absence of factor V Leiden in the Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

Studies on phospholipid antibodies, APC-resistance and associated mutation in the coagulation factor V gene

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2896%2900200-9

7 January 2021

10.1016/S0049-3848(96)00200-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8948063%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference